Investment for health and wellbeing

Oriola’s Half-Year Report 2024 published – read the report here >>

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Half-Year Report 2024 published

Continued sales growth in both segments.

Download the Q2 report Download Q2 presentation Watch the webcast recording

Annual Report 2023

Our Annual Report consists of the following sections: Business review, Sustainability report, Corporate governance statement, Remuneration report, Report of the Board of Directors and Financial statements.

Find out more

Shortcut to investor tools

Key figures Share information Shareholders

Latest stock exchange releases

18.07.2024 | Stock exchange releases

Oriola Corporation’s Half-Year Report January-June 2024
06.06.2024 | Stock exchange releases

Composition of Oriola Corporation’s Shareholders’ Nomination Board
30.04.2024 | Stock exchange releases

The Swedish Competition Authority prohibits Oriola’s sale of Svensk dos AB to Apotekstjänst Sverige AB
See all stock exchange releases from our newsroom Subscribe to releases

Looking for financial reports or other financial information?

Reports and presentations Financial information Investor calendar Investor contacts